Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
about
The extreme N-terminal region of human apolipoprotein A-I has a strong propensity to form amyloid fibrilsApolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosisStructural Insights into High Density Lipoprotein: Old Models and New FactsAmyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structureHuman apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensityAmyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I.AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides.Transthyretin Tyr77 familial amyloid polyneuropathy: a clinicopathological study of a large kindred.Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.Finnish type of familial amyloidosis: cosegregation of Asp187----Asn mutation of gelsolin with the disease in three large families.A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred.Apolipoprotein AI-derived pulmonary vascular amyloid in aged dogs.Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.Cellular interaction and cytotoxicity of the iowa mutation of apolipoprotein A-I (ApoA-IIowa) amyloid mediated by sulfate moieties of heparan sulfate.Ostertag revisited: the inherited systemic amyloidoses without neuropathy.Prediction of aggregation rate and aggregation-prone segments in polypeptide sequences.Alzheimer's disease from the perspective of the systemic and localized forms of amyloidosis.D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.The genetics of the amyloidoses: interactions with immunity and inflammation.Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.Structure, function and amyloidogenic propensity of apolipoprotein A-I.Mapping the structural transition in an amyloidogenic apolipoprotein A-IHereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 geneInherited amyloidosis.Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI geneApolipoprotein A-I: the dual face of a protein.Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis.Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin.Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease.Familial amyloid polyneuropathy.Peripheral nerve amyloidosis.Pulmonary vascular amyloidosis in aged dogs. A new form of spontaneously occurring amyloidosis derived from apolipoprotein AI.Iowa Mutant Apolipoprotein A-I (ApoA-IIowa) Fibrils Target Lysosomes.Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques.Apolipoprotein A-1-related amyloidosis 2 case reports and review of the literature.A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state.Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis.Online registry for mutations in hereditary amyloidosis including nomenclature recommendations.Apolipoprotein A-I induced amyloidosis.Hereditary Fibrinogen Aα-Chain Amyloidosis in Asia: Clinical and Molecular Characteristics.
P2860
Q24311701-B6FDEBD1-1FA9-41DD-819F-CB1C966485B0Q24564368-47510583-6614-4BB6-9B9D-90F1014BA3C8Q26770434-4DC467B3-7A16-4FD8-B0DA-FE4117E09EF9Q28361328-7877A53F-638D-482F-9628-E19BE45E4DC2Q28482893-650A9A2A-83FA-447E-A68F-3AADF6F87E35Q31029305-94CDF391-F0F0-4073-8458-8792354BA083Q33275645-FBD171BD-81D4-49C8-89AE-2E47A4A47AEDQ34475094-808C2FB1-7A36-4C68-AC26-958878A965BEQ34580359-BD07AD4C-2AF7-4BA7-A37D-147832FA0162Q35196805-A91FE163-BE29-42BD-ABBA-D96128AE9522Q35456927-CDAFF2D8-8A22-4D11-851C-A44BA13D7B88Q35795491-E6983CFB-6454-4679-BBF7-983D4CD28F8AQ35978258-4F4C063F-4219-4F8A-847A-8551CD6146CAQ36115813-01A4BE5C-E296-4F2D-91C6-C3707F77471EQ36191449-B40369B5-F628-407F-B195-D3094DC69502Q36476739-44604667-F1E6-445D-B794-32B4CA2E8DE5Q36477010-55BF42A7-D2D5-4D26-B820-27BE55587043Q36528525-94A7496D-353C-44E8-AE25-994FA5CB8F45Q36534748-CEF27E6C-51F4-4FE5-A332-36D30CC05C2FQ36562153-A6B63ECC-713B-4AC5-8AD2-C6BB540B5C6DQ36654590-8F193F3E-0BDA-4F2D-BF88-D0D80174C47AQ36833883-C8166B5F-0331-4D71-BD44-40ABFF14B6DCQ37164492-444B5A4B-6B06-47FE-A543-02C1386957F0Q37165040-42148904-D0C6-4911-815B-FDB7299DFD96Q37356259-DCEAB303-B064-4295-B1E4-DE8C013731D4Q38993412-7B06F87D-3E61-490B-9162-FB1F0928B336Q39713474-454E154C-BE04-4BA3-9EF4-2E8FF97353B6Q40340220-80EF2C3B-81BD-446F-A5AC-5F1E9FE838F6Q40682439-B4BD7D28-84E2-4DF9-A786-8E5D928A9F56Q40807251-1C358055-3486-4820-ACDB-BF27C1F40EC6Q41061839-95FFE038-BC97-48AC-98BB-D87050DE5EEEQ42006167-9DE3E4E8-1958-4936-82F2-D11D64AA34A0Q42038712-65BA5610-5842-4C22-8D8F-8711476C7BD3Q42058414-6E405DC8-0008-46BA-8B54-7A37619A609EQ42283377-639A5D4C-9720-4BD2-9744-CFC9661C3E55Q46830278-36BF2128-24B1-4169-80CB-B63B80AB2384Q46976640-2DABD0AF-2AA5-4A3E-8976-E3D2BD6DB94BQ47590416-CAF398E3-14A5-4E67-8DAC-AE1FB55FB164Q47750057-C92512A8-053B-4C4F-B3E9-53D399446528Q48182611-D46B0752-F1FB-46B5-9D75-4E4CCD97C510
P2860
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
description
1988 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1988
@ast
im Oktober 1988 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1988/10/31)
@sk
vědecký článek publikovaný v roce 1988
@cs
wetenschappelijk artikel (gepubliceerd op 1988/10/31)
@nl
наукова стаття, опублікована в жовтні 1988
@uk
مقالة علمية (نشرت في 31-10-1988)
@ar
name
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@ast
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@en
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@nl
type
label
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@ast
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@en
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@nl
prefLabel
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@ast
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@en
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@nl
P2093
P3181
P1476
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid
@en
P2093
F. E. Dwulet
J. Liepnieks
M. D. Benson
W. C. Nichols
P304
P3181
P356
10.1016/S0006-291X(88)80909-4
P407
P577
1988-10-31T00:00:00Z